The German company, 2invest AG, is listed on the stock exchange and focuses on acquiring, managing, and selling investments in the biotechnology, life science, and IT sectors. They operate both in Germany and abroad, with a particular emphasis on attractive risk/reward profiles and long-term total returns. Their investments include both listed and unlisted companies, as well as financial instruments.